Finepoint Capital LP 13F holdings, Q4 2025
Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →
Finepoint Capital LP disclosed 7 US equity positions worth $532.8m in its Q4 2025 13F filing. The largest position was QXO at 76.7% of the reported book, followed by RXO and SLDB. Against the Q3 2025 filing, it opened 0 new positions, added to 1 and reduced 1 among the top 7 holdings.
What did Finepoint Capital LP own in Q4 2025? Top 7 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2025 |
|---|---|---|---|---|---|---|---|
| 1 | QXO QXO INC | Industrials | 76.7% | $408.5m | 21,177,415 | -5% | reduced |
| 2 | RXO RXO INC | Industrials | 22.3% | $118.7m | 9,388,789 | 29% | added |
| 3 | SLDB SOLID BIOSCIENCES INC | Healthcare | 1.0% | $5.4m | 961,251 | 0% | held |
| 4 | ALEANNA INC | 0.0% | $79.0k | 27,717 | 0% | held | |
| 5 | ALEANNA INC | 0.0% | $69.3k | 490,000 | 0% | held | |
| 6 | MoneyHero Ltd | 0.0% | $38.3k | 895,000 | 0% | held | |
| 7 | CALIDI BIOTHERAPEUTICS INC | 0.0% | $1.2k | 1,042 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.